The Hong Kong stock market's innovative drug sector strengthened, with Ascletis Pharmaceuticals (01672.HK) rising more than 20%, Rongchang Biopharma (09995.HK) and CSPC Pharmaceutical Group (01093.HK) rising more than 6%, and BeiGene (06160.HK) and Innovent Biologics (01801.HK) following suit.

2025-04-22 09:51:32

BeiGene

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Hong Kong Stock Midday Review: Hang Seng Index fell 1.21%, Hang Seng Technology Index fell 2.04%
                            2025-04-24

                                    Tesla's gains in US stocks expanded to 5%
                            2025-04-22

                                    BYD: Net profit in the first quarter increased by 100.38%
                            2025-04-25

                                    Intel fell nearly 4% on the Frankfurt exchange
                            2025-04-25

                                    Chinese AI startup MANUS raises funding at nearly $500 million valuation
                            2025-04-25